ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      96,904.02
      -0.31%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AN2 Therapeutics Inc (ANTX)

      7. AN2 Therapeutics Inc (ANTX) News

      AN2 Therapeutics Inc

      AN2 Therapeutics Inc (ANTX)

      NASDAQ
      1.26
      -0.01
      (-0.79%)
      Closed December 22 4:00PM
      Delayed by 15 minutes
      1.26
      -0.005
      (-0.40%)
      After Hours: 6:24PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      ANTX News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 10 2024
      ANTX (-0.79%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 27 2024
      ANTX (-0.79%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 21 2024
      ANTX (-0.79%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 18 2024
      ANTX (-0.79%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 13 2024
      ANTX (-0.79%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 13 2024
      ANTX (-0.79%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 05 2024
      ANTX (-0.79%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 05 2024
      ANTX (-0.79%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      November 05 2024
      ANTX (-0.79%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 05 2024
      ANTX (-0.79%)

      Form 8-A12B - Registration of securities [Section 12(b)]
      Edgar (US Regulatory)
      August 19 2024
      ANTX (-0.79%)

      ANTX Discussion

      View Posts
      glenn1919 glenn1919 2 weeks ago
      ANTX.....................https://stockcharts.com/h-sc/ui?s=ANTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 weeks ago
      ANTX........................https://stockcharts.com/h-sc/ui?s=ANTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 3 weeks ago
      ANTX NEXT WEEK WATCH
      👍️0
      stocksrising stocksrising 1 month ago
      Open market purchase always welcomed :)..even if tiny 😜

      Common Stock-CEO
      11/18/2024
      50,000
      A
      $0.9994
      1,065,76
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      ANTX MINI BIO BEAST
      👍️ 1
      stocksrising stocksrising 1 month ago
      I haven’t done much DD on this bio, but it seems they have several readouts within 6-12mos. that could propel stock higher (especially with the $$$ runway position)… as you know, any biotech is risky but I like the odds on this one and starter position is small for now…I did copy this from release that I found appealing:

      Boron Chemistry Pipeline

      Additional development programs are underway and focused on targets in infectious diseases and oncology with high unmet needs. The Company anticipates delivering up to three development compounds in 2025.

      Global Health

      In October, the Company announced that it received a second-year continuation of a research grant from the Bill & Melinda Gates Foundation to discover novel boron containing small molecules for the treatment of tuberculosis and malaria. The Company will continue its efforts to tackle global health disease through non-dilutive funding.
      👍️0
      eyeownu eyeownu 1 month ago
      NOPE. took my looses moved them over to $EBS and made it all back. do you notice anything promising that warrants investing in this company besides the cash on hand?
      👍️0
      stocksrising stocksrising 1 month ago
      Picked up a bit more down here at $1ish, you still in??
      👍️0
      Monksdream Monksdream 4 months ago
      ANTX new 52 week low
      👍️0
      Monksdream Monksdream 5 months ago
      ANTX under $3
      👍️0
      eyeownu eyeownu 5 months ago
      looking good
      👍️0
      glenn1919 glenn1919 6 months ago
      ANTX..............https://stockcharts.com/h-sc/ui?s=ANTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      GO4AWILDRIDE GO4AWILDRIDE 9 months ago
      FROM 3/28 NEWS:

      Cash, cash equivalents, and investments of $134.5 million at December 31, 2023

      GO4AWILDRIDE
      👍️0
      GO4AWILDRIDE GO4AWILDRIDE 9 months ago
      THE FOLLOWING FROM THE 3/28 NEWS:

      “AN2’s cash position remains strong as we advance our innovative boron-based pipeline. Following the recent meeting of the independent Data Safety Monitoring Board, we continue to believe in the potential of epetraborole to become an important component of the backbone therapy for NTM lung disease,” said Eric Easom, Co-Founder, President and Chief Executive Officer. “Patients enrolled in the epetraborole Phase 2/3 trial in treatment refractory lung disease caused by MAC continue to be dosed while new enrollment in the Phase 3 part of the trial remains paused. Patients in the Phase 2 trial have reached the six-month mark, and we plan to report topline results this summer. Analysis of the baseline patient demographics from the trial show a highly complex and refractory patient population, which we plan to discuss with the FDA in the coming months.”

      GO4AWILDRIDE
      👍️0
      GO4AWILDRIDE GO4AWILDRIDE 9 months ago
      Monksdream

      Did you read the 3/28 news from the compay?

      Seems like the market is looking to chase the price up.

      GLTU

      GO4AWILDRIDE
      👍️0
      GO4AWILDRIDE GO4AWILDRIDE 9 months ago
      Monksdream

      Seems like a nice rebound is starting to occur.

      GLTU

      GO4AWILDRIDE
      👍️0
      Monksdream Monksdream 10 months ago
      ANTX new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      ANTX new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      ANTX new 52 week low
      👍️0

      Your Recent History

      NASDAQ
      ANTX
      AN2 Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads